Pharmacopsychiatry 2006; 39(1): 13-15
DOI: 10.1055/s-2006-931472
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Effect of Sub-Chronic Treatment with Jarsin® (Extract of St John’s Wort, Hypericum perforatum) at Two Dose Levels on Evening Salivary Melatonin and Cortisol Concentrations in Healthy Male Volunteers

M. Franklin1 , S. Hafizi2 , A. Reed2 , R. Hockney2 , H. Murck3
  • 1Molecular Neurosciences, BMS, Oxford Brookes University, Oxford, UK
  • 2University of Oxford, Department of Psychiatry, Warneford Hospital, Oxford, UK
  • 3Lichtwer Pharma AG, Berlin, Germany
Further Information

Publication History

Received: 8.12.2003 Revised: 25.2.2004

Accepted: 30.8.2005

Publication Date:
02 February 2006 (online)

Objective: The aim of the present study was to measure the effect of two doses of extracts from Hypericum perforatum (HP), Jarsin®, on evening salivary cortisol and NA-mediated melatonin in healthy male volunteers. Methods: Twenty healthy male volunteers were randomly given a low or high dose of Jarsin® for 7 days. Saliva samples for cortisol and melatonin, and overnight urine samples were collected for cortisol and 6-sulfatoxymelatonin and measured by specific radioimmunoassays. Results: Treatment significantly increased salivary cortisol throughout the whole collection period in the low dose group but had no discernable effect in the high dose group. Salivary melatonin was not increased in either dose group following treatment. Conclusion: Salivary cortisol was enhanced in the low dose group only and melatonin was not affected by either treatment. We suggest that HP may enhance salivary cortisol via a U-shaped dose-response relationship and that this may be mediated through a 5-HT2 mechanism.

References

  • 1 Arendt J. In: Melatonin and mammalian pineal gland. Pub Chapman and Hall London, UK; 1995: p 35
  • 2 Butterweck V, Wall A, Lieflander-Wulf U, Winterhoff H, Nahrstadt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.  Pharmacopsychiatry. 1997;  30(Suppl) 117-124
  • 3 Dimpfel W, Schober F, Mannel M. Effects of a methanolic extract and a hyperforin-enriched extract of St John’s wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-stereo-EEG).  Pharmacopsychiatry. 1998;  31(Suppl 1) 30-35
  • 4 Franklin M. Sub-chronic treatment effects of an extract of Hypericum perforatum (St John’s wort, Li 160) on neuroendocrine responses to the 5-HT2A agonist, DOI in the rat.  Pharmacopsychiatry. 2003;  36 161-164
  • 5 Franklin M, Chi J, Mannel M, Cowen P J. Acute effects of LI 160 (extract of Hypericum perforatum, St John’s wort) and two of its constituents on neuroendocrine responses in the rat.  J Psychopharmacol. 2000;  14 360-363
  • 6 Franklin M, Chi J, McGavin C, Hockney R, Reed A, Campling G, Whale R WR, Cowen P J. Neuroendocrine evidence for dopaminergic actions of Hypericum extract (LI 160) in healthy volunteers.  Biol Psychiatry. 1999;  46 199-202
  • 7 Franklin M, Clement E M, Campling G, Cowen P J. Effect of venlafaxine on melatonin and noradrenaline in the male rat.  J Psychopharmacol. 1998;  12 403-406
  • 8 Franklin M, Cowen P J. Researching the antidepressant actions of Hypericum perforatum (St John’s wort) in animals and man.  Pharmacopsychiatry. 2001;  34 (Suppl 1) S29-37
  • 9 Franklin M, McGavin C, Reed A, Cowen P J. Effect of Hypericum perforatum on salivary cortisol in healthy male volunteers.  J Psychopharmacol. 1998;  30 (Suppl) A16
  • 10 Franklin M, Reed A, Murck H. Sub-chronic treatment with an extract of Hypericum perforatum (St John’s wort) significantly reduces cortisol and corticosterone in the rat brain.  Eur Neuropsychophamacol. 2004;  14 7-10
  • 11 Held K, Antonijevic I A, Kunzel H, Uhr M, Wetter T C, Golly I C, Stei A, Murck H. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.  Pharamcopsychiatry. 2002;  35 135-143
  • 12 Kehr J, Yoshitake S, Yoshitake T, Ogren S O. Differential effects of acute and repeated administration of Hypericum perforatum (St John’s wort) on extracellular levels of serotonin, noradrenaline and dopamine in prefrontal cortex, striatum and hippocampus of the rat.  European Neuropsychomarmacol. 2002;  12 (Suppl 3) S203
  • 13 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St John’s wort for depression an overview and meta-analysis of randomised clinical trials.  BMJ. 1996;  313 253-258
  • 14 Muller W E, Singer A, Wonnermann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract.  Pharmacopsychiatry. 1998;  31 16-21
  • 15 Rommelspacher H, Siemanowitz B, Mannel M. Acute and chronic actions of methanolic extract of Hypericum perforatum and a hyperforin-rich extract on dopaminergic and serotonergic neurones in rat nucleus accumbens.  Pharmacopsychiatry. 2001;  34 (Suppl 1) S119-126
  • 16 Van Cauter E, Leproult R, Kupfer D J. Effects of gender and age on levels and circadian rhythms of plasma cortisol.  J Clin Endocrinol Metab. 1996;  81 2468-2473

Dr. M. Franklin

Molecular Neurosciences

BMS

Oxford Brookes University

Oxford OX3 0BP

UK

Email: michael.franklin@psychiatry.oxford.ac.uk

    >